218 related articles for article (PubMed ID: 28991170)
1. Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections.
Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Shapiro NI
J Clin Med; 2017 Oct; 6(10):. PubMed ID: 28991170
[TBL] [Abstract][Full Text] [Related]
2. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever.
Shapiro NI; Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Sambursky R
Ann Med; 2018 Aug; 50(5):420-429. PubMed ID: 29775092
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection.
Sambursky R; Shapiro N
Eur Clin Respir J; 2015; 2():28245. PubMed ID: 26672961
[TBL] [Abstract][Full Text] [Related]
4. Performance of the FebriDx Rapid Point-of-Care Test for Differentiating Bacterial and Viral Respiratory Tract Infections in Patients with a Suspected Respiratory Tract Infection in the Emergency Department.
Tong-Minh K; Daenen K; Endeman H; Ramakers C; Gommers D; van Gorp E; van der Does Y
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202172
[TBL] [Abstract][Full Text] [Related]
5. Utility of the FebriDx point-of-care test for rapid triage and identification of possible coronavirus disease 2019 (COVID-19).
Karim N; Ashraf MZ; Naeem M; Anwar T; Aung H; Mallik S; Avraam E; Kiran S; Bandapaati S; Khan F; Tsaknis G; Reddy R
Int J Clin Pract; 2021 Mar; 75(3):e13702. PubMed ID: 32896946
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting.
Shapiro NI; Filbin MR; Hou PC; Kurz MC; Han JH; Aufderheide TP; Ward MA; Pulia MS; Birkhahn RH; Diaz JL; Hughes TL; Harsch MR; Bell A; Suarez-Cuervo C; Sambursky R
JAMA Netw Open; 2022 Oct; 5(10):e2234588. PubMed ID: 36255727
[TBL] [Abstract][Full Text] [Related]
7. Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.
Joseph P; Godofsky E
Open Forum Infect Dis; 2018 Feb; 5(2):ofy024. PubMed ID: 29479553
[TBL] [Abstract][Full Text] [Related]
8. FebriDx
Shirley M
Mol Diagn Ther; 2019 Dec; 23(6):803-809. PubMed ID: 31691924
[TBL] [Abstract][Full Text] [Related]
9. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
Lagi F; Trevisan S; Piccica M; Graziani L; Basile G; Mencarini J; Borchi B; Menicacci L; Vaudo M; Scotti V; Fabbri A; Bandini G; Tozzetti C; Berni A; Aiezza N; Pestelli G; Turchi V; Pignone AM; Poggesi L; Nozzoli C; Morettini A; Rossolini GM; Bartoloni A
Int J Infect Dis; 2021 Jul; 108():231-236. PubMed ID: 33901656
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of C-reactive protein and myxovirus resistance protein A to guide the rational use of antibiotics among acute febrile adult patients in Northwest Ethiopia.
Akelew Y; Derbew A; Lemma M; Negash M; Bewket G; Belay G; Pollmann J; Adriaensen W; Adane A; Mohammed R; van Griensven J; Cnops L
Int J Infect Dis; 2020 Dec; 101():276-282. PubMed ID: 33002622
[TBL] [Abstract][Full Text] [Related]
11. Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States.
Dick K; Schneider J
J Health Econ Outcomes Res; 2021; 8(2):56-62. PubMed ID: 34703832
[No Abstract] [Full Text] [Related]
12. Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study.
Wilcox CR; Odeh N; Clark TW; Muller I; Becque T; Todd A; Islam N; Little P; Davies F; McGavin J; Francis N
J Antimicrob Chemother; 2024 Jun; 79(6):1441-1449. PubMed ID: 38708643
[TBL] [Abstract][Full Text] [Related]
13. Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study.
Brendish NJ; Tanner AR; Poole S; Beard KR; Naidu VV; Mansbridge CT; Norton NJ; Wheeler H; Presland L; Clark TW
Infect Dis Ther; 2022 Jun; 11(3):1267-1280. PubMed ID: 35534764
[TBL] [Abstract][Full Text] [Related]
14. Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection.
Ko ER; Henao R; Frankey K; Petzold EA; Isner PD; Jaehne AK; Allen N; Gardner-Gray J; Hurst G; Pflaum-Carlson J; Jayaprakash N; Rivers EP; Wang H; Ugalde I; Amanullah S; Mercurio L; Chun TH; May L; Hickey RW; Lazarus JE; Gunaratne SH; Pallin DJ; Jambaulikar G; Huckins DS; Ampofo K; Jhaveri R; Jiang Y; Komarow L; Evans SR; Ginsburg GS; Tillekeratne LG; McClain MT; Burke TW; Woods CW; Tsalik EL;
JAMA Netw Open; 2022 Apr; 5(4):e227299. PubMed ID: 35420659
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of FebriDx® for the management of children with acute febrile respiratory infection.
de la Matta Farrando P; Suay Torres MT; Sabater Sabate A; Trenchs Sainz de la Maza V; Luaces Cubells C; Hernández Bou S
Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):313-316. PubMed ID: 38688819
[TBL] [Abstract][Full Text] [Related]
16. Utility of the FebriDx point-of-care assay in supporting a triage algorithm for medical admissions with possible COVID-19: an observational cohort study.
Houston H; Deas G; Naik S; Shah K; Patel S; Greca Dottori M; Tay M; Filson SA; Biggin-Lamming J; Ross J; Vaughan N; Vaid N; Gopal Rao G; Amin AK; Gupta-Wright A; John L
BMJ Open; 2021 Aug; 11(8):e049179. PubMed ID: 34373308
[TBL] [Abstract][Full Text] [Related]
17. Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein.
Iliopoulou K; Koufargyris P; Doulou S; Tasouli E; Katopodis S; Chachali SP; Schinas G; Karachalios C; Astriti M; Katsaounou P; Chrysos G; Seferlis T; Dimopoulou E; Kollia M; Poulakou G; Gerakari S; Papanikolaou IC; Milionis H; Dalekos GN; Tzavara V; Kontopoulou T; Giamarellos-Bourboulis EJ
Infect Dis Ther; 2024 Jan; 13(1):105-119. PubMed ID: 38112973
[TBL] [Abstract][Full Text] [Related]
18. Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute Infection.
Piri R; Yahya M; Ivaska L; Toivonen L; Lempainen J; Nuolivirta K; Tripathi L; Waris M; Peltola V
Microbiol Spectr; 2022 Feb; 10(1):e0203121. PubMed ID: 35080443
[TBL] [Abstract][Full Text] [Related]
19. Use of the FebriDx® point-of-care-test for lower respiratory tract infections in primary care: a qualitative interview study.
Rutter J; Wilcox C; Odeh N; Muller I; Clark TW; Little P; Davies F; McGavin J; Francis N
BJGP Open; 2024 Apr; ():. PubMed ID: 38688532
[TBL] [Abstract][Full Text] [Related]
20. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study.
van Houten CB; de Groot JAH; Klein A; Srugo I; Chistyakov I; de Waal W; Meijssen CB; Avis W; Wolfs TFW; Shachor-Meyouhas Y; Stein M; Sanders EAM; Bont LJ
Lancet Infect Dis; 2017 Apr; 17(4):431-440. PubMed ID: 28012942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
